Evidence map›Paper›PMID 24799710›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2014

Basal NF-κB controls IL-7 responsiveness of quiescent naïve T cells.

Michelle L Miller, Mona Mashayekhi, Luqiu Chen, Ping Zhou, Xindong Liu, Monica Michelotti, Nicole Tramontini Gunn, Sarah Powers, Xiaoping Zhu, Cesar Evaristo and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
1.3field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 41 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Pharmaceutical biology · 2020
    Article
  17. Review
  18. Article
  19. Article
  20. Hepatoprotective Effects ofOxidative medicine and cellular longevity · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Michelle L MillerDepartment of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; and.
Mona MashayekhiDepartment of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; and.
Luqiu ChenDepartment of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; and.
Ping ZhouDepartment of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; and.
Xindong LiuLaboratory of Immunology, Virginia-Maryland Regional College of Veterinary Medicine, University of Maryland, College Park, MD 20742.
Monica MichelottiDepartment of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; and.
Nicole Tramontini GunnDepartment of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; and.
Sarah PowersDepartment of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; and.
Xiaoping ZhuLaboratory of Immunology, Virginia-Maryland Regional College of Veterinary Medicine, University of Maryland, College Park, MD 20742.
Cesar EvaristoDepartment of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; and.
Maria-Luisa AlegreDepartment of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; and.
Luciana L MolineroDepartment of Medicine, Section of Rheumatology, University of Chicago, Chicago, IL 60637; and lucianamolinero@gmail.com.
University of Chicago · USUniversity of Maryland, College Park · USVirginia–Maryland College of Veterinary Medicine · US

Funding

Re-Engineering Translational Research at the University of ChicagoUL1TR000430 · NCATS · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2012 to 2016
$20.2M
Transcytosis of IgG in Genital InfectionsR01AI065892 · NIAID · UNIV OF MARYLAND, COLLEGE PARK · PI ZHU, XIAOPING · 2007 to 2010
$1.2M
A B-CELL SPECIFIC COFACTOR OF NUCLEOSOME REMODELINGF32AI010523 · NIAID · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI NOVINA, CARL D · 2000 to 2002
$128k
NCATS NIH HHS UL1 TR000430NIAID NIH HHS AI065892NIAID NIH HHS AI1052352NIAID NIH HHS R01 AI065892
6 · The paper itself

Abstract

T cells are essential for immune defenses against pathogens, such that viability of naïve T cells before antigen encounter is critical to preserve a polyclonal repertoire and prevent immunodeficiencies. The viability of naïve T cells before antigen recognition is ensured by IL-7, which drives expression of the prosurvival factor Bcl-2. Quiescent naïve T cells have low basal activity of the transcription factor NF-κB, which was assumed to have no functional consequences. In contrast to this postulate, our data show that basal nuclear NF-κB activity plays an important role in the transcription of IL-7 receptor α-subunit (CD127), enabling responsiveness of naïve T cells to the prosurvival effects of IL-7 and allowing T-cell persistence in vivo. Moreover, we show that this property of basal NF-κB activity is shared by mouse and human naïve T cells. Thus, NF-κB drives a distinct transcriptional program in T cells before antigen encounter by controlling susceptibility to IL-7. Our results reveal an evolutionarily conserved role of NF-κB in T cells before antigenic stimulation and identify a novel molecular pathway that controls T-cell homeostasis.

Indexed as

Gene Expression RegulationAnimalsAntigensCell SurvivalHumansI-kappa B KinaseInflammationInterleukin-7Interleukin-7 Receptor alpha SubunitLymphocyte ActivationMiceMice, Inbred C57BLMice, TransgenicNF-kappa B p50 SubunitReceptors, Interleukin-7Recombinant ProteinsAntigensI-kappa B KinaseInterleukin-7Interleukin-7 Receptor alpha SubunitNF-kappa B p50 SubunitNFKB1 protein, humanNfkb1 protein, mouseReceptors, Interleukin-7Recombinant ProteinsSTAT5 Transcription FactorIkBaDNIKKβIl7r enhancerSTAT5

Identifiers

PMID24799710
PMCPMC4034246
OpenAlexW1992163987

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.